These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 21565614)

  • 21. The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.
    Baran K; Yang M; Dillon CP; Samson LL; Green DR
    Cell Death Differ; 2017 Nov; 24(11):1925-1936. PubMed ID: 28753207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of p53 in the Regulation of Cellular Senescence.
    Mijit M; Caracciolo V; Melillo A; Amicarelli F; Giordano A
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32182711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Senescence and aging: the critical roles of p53.
    Rufini A; Tucci P; Celardo I; Melino G
    Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
    Bissonnette N; Wasylyk B; Hunting DJ
    Biochem Cell Biol; 1997; 75(4):351-8. PubMed ID: 9493957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging.
    Li T; Liu X; Jiang L; Manfredi J; Zha S; Gu W
    Oncotarget; 2016 Mar; 7(11):11838-49. PubMed ID: 26943586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.
    Indeglia A; Murphy ME
    Crit Rev Biochem Mol Biol; 2024; 59(1-2):128-138. PubMed ID: 38661126
    [No Abstract]   [Full Text] [Related]  

  • 28. p53 stabilization and transactivation by a von Hippel-Lindau protein.
    Roe JS; Kim H; Lee SM; Kim ST; Cho EJ; Youn HD
    Mol Cell; 2006 May; 22(3):395-405. PubMed ID: 16678111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of a mutant p53 protein in apoptosis: characterization of a function independent of transcriptional trans-activation.
    Guillouf C; Rosselli F; Sjin RT; Moustacchi E; Hoffman B; Liebermann DA
    Int J Oncol; 1998 Jul; 13(1):107-14. PubMed ID: 9625811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain.
    Suzuki S; Tsutsumi S; Chen Y; Ozeki C; Okabe A; Kawase T; Aburatani H; Ohki R
    Cancer Sci; 2020 Feb; 111(2):451-466. PubMed ID: 31834974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering p53 signaling in tumor suppression.
    Mello SS; Attardi LD
    Curr Opin Cell Biol; 2018 Apr; 51():65-72. PubMed ID: 29195118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
    Timofeev O; Schlereth K; Wanzel M; Braun A; Nieswandt B; Pagenstecher A; Rosenwald A; Elsässer HP; Stiewe T
    Cell Rep; 2013 May; 3(5):1512-25. PubMed ID: 23665223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses.
    Chao C; Hergenhahn M; Kaeser MD; Wu Z; Saito S; Iggo R; Hollstein M; Appella E; Xu Y
    J Biol Chem; 2003 Oct; 278(42):41028-33. PubMed ID: 12909629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.
    Chen X; Ko LJ; Jayaraman L; Prives C
    Genes Dev; 1996 Oct; 10(19):2438-51. PubMed ID: 8843196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
    Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
    Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair.
    Boehden GS; Akyüz N; Roemer K; Wiesmüller L
    Oncogene; 2003 Jun; 22(26):4111-7. PubMed ID: 12821945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.
    Kobayashi T; Ishida J; Musashi M; Ota S; Yoshida T; Shimizu Y; Chuma M; Kawakami H; Asaka M; Tanaka J; Imamura M; Kobayashi M; Itoh H; Edamatsu H; Sutherland LC; Brachmann RK
    Int J Cancer; 2011 Jan; 128(2):304-18. PubMed ID: 20309933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.
    Carlsen L; El-Deiry WS
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.